Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In a double blind, randomized trial involving 151 patients with ovarian cancer treated with cisplatin, intravenous glutathione therapy was shown to reduce the toxicity of cisplatin and improve quality of life
Third, the compound has shown a favorable safety profile in preclinical studies
Provided as a binary lyophilized reference standard for analytical method development
Benefits: The product provides ready-made glutathione, not just its precursors
BPC-157 is studied for tissue protection and gastrointestinal barrier research, TB-500 (a thymosin beta-4 fragment) for actin sequestering and cell migration research, and GHK-Cu for extracellular matrix remodeling research
To better understand why delivery matters, it helps to start with All About Liposomes
US$ 27.00
US$ 25.91
US$ 25.23
US$ 22.74
US$ 29.86
